Zoll Medical gets attention from Wall Street
Investors are starting to notice S&P 600 stocks that are projected to have double-digit increases in sales and earnings.
A stock that has received recent notice on Wall Street is Zoll Medical (Zoll) which designs, manufactures and markets an integrated line of proprietary, noninvasive cardiac resuscitation devices, external pacemaker/defibrillators, disposable electrodes, mobile ECG Systems and EMS data management solutions. The recent price momentum has been a result of upgrades in the projections for sales and earnings.
Barchart technical indicators of recent price momentum:
- 100% Barchart technical buy signals
- Trend Spotter buy signals
- Above it's 20, 50 and 100 day moving averages
- 4 new highs and up 20.06% in the last month
- Relative Strength Index is 74.72% and rising
- Trades around 69.00 which is above its 50 day moving average of 57.45
- Barchart calculates a 61.99 support level
- Wall Street brokerage analysts have recently discovered this S&P 600 stock and released 6 strong buy, 1 buy and 1 hold recommendations to their clients based on double digit projections for sales and earnings increases
- Sales are projected to increase by 14.20% this year and another 15.30% next year
- Earnings are forecast to increase by 46.00% this year, 37.00% next year and continue to increase by 32.50% annually for the next 5 years
Chart and data provided by Barchart
| Tags: | investing strategy |
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
STOCK SCOUTER
StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.
127 | 269 | 463 | 587 | 658 | 616 | 645 | 430 | 262 | 137 |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
LATEST POSTS
All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.